GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Samil Pharmaceutical Co Ltd (XKRX:000520) » Definitions » Cyclically Adjusted Price-to-FCF

Samil Pharmaceutical Co (XKRX:000520) Cyclically Adjusted Price-to-FCF : (As of May. 18, 2024)


View and export this data going back to 1985. Start your Free Trial

What is Samil Pharmaceutical Co Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Samil Pharmaceutical Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Samil Pharmaceutical Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Samil Pharmaceutical Co Cyclically Adjusted Price-to-FCF Chart

Samil Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Samil Pharmaceutical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Samil Pharmaceutical Co's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Samil Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Samil Pharmaceutical Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Samil Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Samil Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.



Samil Pharmaceutical Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Samil Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Samil Pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=358.264/118.8477*118.8477
=358.264

Current CPI (Dec. 2023) = 118.8477.

Samil Pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 -101.893 99.253 -122.009
201406 -732.849 99.353 -876.646
201409 -513.990 99.608 -613.269
201412 -160.332 99.098 -192.285
201503 -4.282 99.720 -5.103
201506 21.982 100.050 26.112
201509 -188.321 100.110 -223.569
201512 200.496 100.220 237.762
201603 -134.098 100.560 -158.485
201606 302.911 100.790 357.181
201609 136.894 101.460 160.354
201612 -207.151 101.560 -242.413
201703 -185.633 102.850 -214.507
201706 -3,306.510 102.610 -3,829.754
201709 -142.663 103.490 -163.834
201712 218.535 102.990 252.184
201803 -214.760 104.100 -245.185
201806 -113.587 104.130 -129.641
201809 -124.324 105.650 -139.854
201812 -100.370 104.350 -114.315
201903 -248.286 104.490 -282.402
201906 443.625 104.880 502.706
201909 -1,095.374 105.200 -1,237.478
201912 618.392 105.120 699.148
202003 224.982 105.540 253.350
202006 -235.464 104.870 -266.848
202009 -185.464 106.200 -207.552
202012 -282.974 105.765 -317.976
202103 -277.232 107.357 -306.904
202106 -450.836 107.579 -498.062
202109 -554.129 108.759 -605.530
202112 -724.394 109.676 -784.969
202203 -826.874 111.806 -878.953
202206 -748.429 114.083 -779.689
202209 -1,296.285 114.831 -1,341.625
202212 -42.197 115.200 -43.533
202303 -32.807 116.550 -33.454
202306 -318.645 117.140 -323.291
202309 -540.950 119.111 -539.753
202312 358.264 118.848 358.264

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Samil Pharmaceutical Co  (XKRX:000520) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Samil Pharmaceutical Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Samil Pharmaceutical Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Samil Pharmaceutical Co (XKRX:000520) Business Description

Traded in Other Exchanges
N/A
Address
990-1, Bangbae-dong, Seocho-Gu, Seoul, KOR, 137-060
Samil Pharmaceutical Co Ltd is engaged in manufacturing and distribution of pharmaceutical products and medicines in South Korea. Its products portfolio consists of gastrointestinal drugs such as antiulcerants, gastroprokinetic agents, digestive enzymes with nutrients and laxatives.

Samil Pharmaceutical Co (XKRX:000520) Headlines

No Headlines